Jeffrey B. Landau - Chief Business Officer at CytomX Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
CTMX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jeffrey B. Landau - trading volume in the past year for CytomX Therapeutics, Inc.

Holdings reported by Jeffrey B. Landau for CytomX Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 119K $146K $1.23 Aug 20, 2024 Direct
Common Stock 4.5K $5.53K $1.23 Aug 20, 2024 Fidelity Traditional IRA
Common Stock 3.18K $3.91K $1.23 Aug 20, 2024 Schwab ROTH IRA
Performance Stock Units (PSUs) 0 $0 $1.23 Aug 20, 2024 Direct Common Stock
Stock Option (Right to Buy) 140K Jan 18, 2024 Direct Common Stock

Transactions reported by Jeffrey B. Landau for CytomX Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.